Description

KLOW is an advanced multi-peptide research matrix designed for the study of systemic tissue repair, deep-level inflammation modulation, and cellular resilience. This 80mg blend synergizes four of the most widely researched regenerative compounds: GHK-Cu, BPC-157, TB-500, and KPV. By combining these distinct molecular pathways, KLOW provides a comprehensive model for investigating coordinated healing across musculoskeletal, epithelial, and vascular systems.

• Purity: >99% per component (HPLC Tested)

• Format: Lyophilized Light Blue Powder

• Composition: GHK-Cu (50mg), BPC-157 (10mg), TB-500 (10mg), KPV (10mg)

• Research Target: Synergistic Tissue Regeneration & NF-κB Pathway Modulation

The KLOW Blend represents a “Total Recovery” model in peptide science. While standard regenerative blends focus primarily on growth factors, KLOW integrates KPV (Lys-Pro-Val) to specifically address the inflammatory “brakes” that often stall tissue repair. This quadruple synergy allows researchers to observe the simultaneous activation of collagen synthesis (GHK-Cu), angiogenic signaling (BPC-157), cellular migration (TB-500), and potent cytokine suppression (KPV).

Research Observed Outcomes

Data from multi-pathway regenerative studies highlight the following physiological impacts in test models:

• Deep Tissue & Gut Repair: The synergy of BPC-157 and KPV is studied for its dual-action repair of epithelial linings and gastrointestinal membranes.

• Coordinated Angiogenesis: Combined TB-500 and BPC-157 exposure has been shown to significantly increase microvascular density and blood flow to injury sites.

• Extracellular Matrix (ECM) Remodeling: High-dose GHK-Cu (50mg) promotes the synthesis of collagen, elastin, and glycosaminoglycans while regulating metalloproteinase activity.

• Potent Anti-Inflammatory Signaling: KPV facilitates the downregulation of the NF-κB pathway, reducing pro-inflammatory cytokines like TNF-α and IL-6 without suppressing systemic immunity.

• Mitochondrial & Oxidative Support: Research suggests this blend helps protect cells from oxidative stress during the metabolic “rebuilding” phase of recovery.

Key Linked Studies & Research References

• Quad-Blend Synergy: Pickart L, & Margolina A. (2018). “Regenerative and Protective Actions of the GHK-Cu Peptide in Light of the New Gene Data.” International Journal of Molecular Sciences.

• Inflammation Modulation (KPV): Dalmasso G, et al. (2008). “The tripeptide KPV reduces intestinal inflammation.” Journal of Biological Chemistry.

• Vascular Stability: Hsieh MJ, et al. (2020). “Modulatory effects of BPC 157 on vasomotor tone and Src-Caveolin-1 activation.” Scientific Reports.

• Actin Dynamics (TB-500): Lee IT, et al. (2021). “Thymosin β4 promotes mesenchymal stem cell proliferation via the PI3K/Akt pathway.” Experimental and Therapeutic Medicine.

Storage & Stability Protocols

• Lyophilized Powder: Store at -20°C for long-term stability. The 80mg composite vial is vacuum-sealed to prevent oxidation of the GHK-Cu copper complex.

• Reconstituted Stability (Bacteriostatic Water): Stability is maintained for 4 weeks when refrigerated (2°C – 8°C). The solution will appear blue due to the high GHK-Cu content.

• Reconstituted Stability (Sterile Water): Stability is shorter, typically 7–10 days.

• Handling: Avoid exposure to direct UV light, which can degrade the tripeptide components.

⚠️ STRICT COMPLIANCE NOTICE: FOR LABORATORY RESEARCH ONLY This product is a chemical substance intended strictly for in vitro or laboratory experimentation. Any form of ingestion, injection, or topical application to humans or animals is STRICTLY PROHIBITED. This product is not a drug, food, or cosmetic and has not been approved by the FDA for any medical application. Handling should only be performed by qualified professionals in a controlled environment.